Validation of the First Brazilian Instrument for Patient Engagement in Patient Safety

Why It Matters

The tool gives Brazil a standardized way to gauge patient involvement in safety, a critical driver of care quality and risk reduction in a large, evolving healthcare market.

Key Takeaways

• First validated Brazilian patient safety engagement instrument.
• 97.9% item equivalence achieved in adaptation.
• Content Validity Index reached 99.6% across items.
• Inter‑rater agreement hit 99.0% in Delphi rounds.
• Tool ready for nationwide implementation and research.

Pulse Analysis

Patient safety remains a top priority worldwide, and engaging patients directly is recognized as a powerful lever to reduce errors and improve outcomes. While high‑income countries have long used structured surveys to monitor this engagement, Brazil has lacked a culturally adapted instrument, limiting systematic assessment and benchmarking. Introducing a validated Portuguese version fills that gap, aligning Brazil with global best practices and enabling health systems to capture patient perspectives on safety initiatives more accurately.

The study’s methodological rigor sets a new standard for instrument adaptation in emerging markets. By following a six‑stage translation, back‑translation, and pre‑test protocol, the researchers ensured linguistic and conceptual fidelity, achieving 97.9% item equivalence. The subsequent Delphi rounds, involving a multidisciplinary expert panel—including a patient partner—produced a Content Validity Index of 99.6% and an inter‑rater agreement of 99.0%, metrics that signal exceptional reliability and relevance. Such high validation scores demonstrate that the tool can be confidently deployed across diverse Brazilian health settings without sacrificing measurement precision.

For Brazilian hospitals, clinics, and policy makers, the availability of this instrument opens pathways to data‑driven quality improvement. Organizations can now benchmark patient engagement levels, identify safety gaps, and track the impact of interventions over time. Moreover, researchers gain a robust metric for longitudinal studies, potentially influencing national safety standards and reimbursement models. As the Brazilian healthcare market continues to expand, the tool positions the country to attract investment in safety‑focused technologies and services, reinforcing a culture where patients are active partners in safeguarding their own care.